| 翻訳と辞書 |
Fucoidan
Fucoidan is a sulfated polysaccharide (MW: average 20,000) found mainly in various species of brown algae and brown seaweed such as mozuku, kombu, bladderwrack, wakame, and hijiki (variant forms of fucoidan have also been found in animal species, including the sea cucumber). Fucoidan is used as an ingredient in some dietary supplement products.
Fucoidan designates a group of certain fucose-containing sulfated polysaccharides (FCSPs) that have a backbone built of (1→3)-linked α-l-fucopyranosyl or of alternating (1→3)- and (1→4)-linked α-l-fucopyranosyl residues, but also include sulfated galactofucans with backbones built of (1→6)-β-d-galacto- and/or (1→2)-β-d-mannopyranosyl units with fucose or fuco-oligosaccharide branching, and/or glucuronic acid, xylose or glucose substitutions. These FCSPs offer several potentially beneficial bioactive functions for humans. The bioactive properties may vary depending on the source of seaweed, the compositional and structural traits, the content (charge density), distribution, and bonding of the sulfate substitutions, and the purity of the FCSP product. The preservation of the structural integrity of the FCSP molecules essentially depends on the extraction methodology which has a crucial, but partly overlooked, significance for obtaining the relevant structural features required for specific biological activities and for elucidating structure-function relations.
== Research ==
There are at least two distinct forms of fucoidan: F-fucoidan, which is >95% composed of sulfated esters of fucose, and U-fucoidan, which is approximately 20% glucuronic acid.
The physiological and biochemical effects of fucoidan have been examined in several small-scale in vitro and animal studies. F-fucoidan was reported to inhibit hyperplasia in rabbits and induce apoptosis in isolated human lymphoma cell lines in vitro. It has been hypothesized that these two effects may involve a common mechanism, but the evidence is inconsistent and no mechanism for the putative induction of apoptosis by fucoidan has been identified. A study in rats indicated that pre-treatment with fucoidan increases mortality subsequent to meningitis infection. In a clinical study, orally-ingested Undaria-derived-fucoidan was reported to produce a small increase in the total number of CD34+ cells, and a more pronounced increase in the proportion of CD34+ cells that expressed CXCR4 (connected to over 23 types of cancers). The authors of the study hypothesized that the ability of fucoidan to mobilize hematopoetic cells with high levels of CXCR4 expression could be clinically valuable.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Fucoidan」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|